Polyclinique Saint Privat

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer2 trials
• Gastric and oesophageal cancer1 trial
• Kidney cancer1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Completed2 trials
• Recruiting2 trials

Lead sponsor

• Federation Francophone de Cancerologie Digestive3 trials
• Institut Gustave Roussy1 trial

Running trials

• Recruiting

  CARE1: FIRST LINE RANDOMISED STUDY PLATFORM TO OPTIMIZE TREATMENT IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

  2023-503317-29-00· Phase 3· Institut Gustave Roussy· Source

• Recruiting

  Prospective National Cohort Evaluating Predictive Biomarkers of Resistance to Immunotherapy in Patients With MSI/dMMR Metastatic Colorectal Cancer (CORESIM)

  NCT06353854· Federation Francophone de Cancerologie Digestive· Source

  Contact: Michaël HUMMELSBERGER, Dr

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer1 recruiting
• Kidney cancer1 recruiting

Closed trials

• Completed

  FOLFOX + Panitumumab According to a "Stop and go" Strategy With a Reintroduction Loop After Progression on Fluoropyrimidine as Maintenance Treatment, as the First Line in Patients With Metastatic Colorectal Adenocarcinoma Without a RAS Mutation

  NCT03584711· Phase 2· Federation Francophone de Cancerologie Digestive· Source

• Completed

  PHASE III RANDOMISED TRIAL to EVALUATE FOLFOX with or WITHOUT DOCETAXEL (TFOX) AS 1st LINE CHEMOTHERAPY for LOCALLY ADVANCED or METASTATIC OESOPHAGO-GASTRIC CARCINOMA

  NCT03006432· Phase 3· Federation Francophone de Cancerologie Digestive· Source